Kidney Diseases  >>  Remozen (remogliflozin etabonate)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Remozen (remogliflozin etabonate) / Islet Sci
NCT00501462: A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

Completed
1
29
US
GSK189075
GlaxoSmithKline
Type 2 Diabetes Mellitus, Diabetes Mellitus, Type 2, Renal Insufficiency
03/08
03/08

Download Options